CSPC Pharmaceutical Grants 46.5 Million Restricted Shares to 727 Employees

CSPC Pharmaceutical Group ( (HK:1093) ) just unveiled an update.

CSPC Pharmaceutical Group has granted 46,462,500 restricted shares, equivalent to about 0.4% of its issued share capital, to 727 selected employees under its restricted share award scheme at nil consideration. The shares will vest in three equal tranches between January 2027 and January 2029, subject to individual performance targets over three consecutive financial years and a clawback mechanism tied to misconduct or regulatory breaches, underscoring the company’s use of equity incentives to retain and motivate staff while leaving 61,575,868 shares available for future grants under the scheme.

The most recent analyst rating on (HK:1093) stock is a Hold with a HK$10.50 price target. To see the full list of analyst forecasts on CSPC Pharmaceutical Group stock, see the HK:1093 Stock Forecast page.

More about CSPC Pharmaceutical Group

CSPC Pharmaceutical Group is a Hong Kong–incorporated pharmaceutical company focused on the research, development, manufacturing and sale of medicines and related healthcare products, serving both domestic and international markets through a broad portfolio of innovative and generic drugs.

Average Trading Volume: 122,113,498

Technical Sentiment Signal: Strong Buy

Current Market Cap: HK$111.9B

See more data about 1093 stock on TipRanks’ Stock Analysis page.